The Macrobead Trial
Helping Patients Every Step of the Way
A Clinical Trial for Patients with Treatment-Resistant, Metastatic Colorectal and Pancreatic Cancer
The clinical research study of an investigational (FDA IND-BB 10091) treatment for patients with pancreatic cancer (all stages), and advanced colorectal cancer that no longer responds to standard therapies.
Macrobeads consist of small beads that contain mouse cancer cells from a mouse kidney cancer cell line. The cells in the beads produce substances that have been shown to slow or stop the growth of tumors in experimental animals and veterinary patients.
The Rogosin Institute is the premier not-for-profit medical treatment and research institution for kidney disease, including dialysis and transplantation, in New York City. Its skilled staff includes dedicated physicians who can provide the best and most comprehensive treatment for your kidney disease.
© 2018 by The Rogosin Institute